Shanhuang Jiangzhi tablets mitigate atherosclerosis by modulating macrophage polarization and inhibiting foam cell formation via the ROS/TLR4/NF-κB pathway

Journal of Pharmacy and Pharmacology · Published 2026-07-01 · DOI 10.1093/jpp/rgag079

Authors (9)

Yingwei Chang, Qing Liu, Qixuan Guo, Zimeng Huang, Ang Lv, Lei Wang, Hongfeng He, Yuqiang Zhang, Xiuwen Liang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Chang, Y., Liu, Q., Guo, Q., et al. (2026). Shanhuang Jiangzhi tablets mitigate atherosclerosis by modulating macrophage polarization and inhibiting foam cell formation via the ROS/TLR4/NF-κB pathway. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgag079

Related articles